Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Strategic Partnership Signals New Age of Stratified Medicine

Published: Thursday, May 02, 2013
Last Updated: Thursday, May 02, 2013
Bookmark and Share
Aridhia and Pivotal™ collaborating on revolutionary solutions for chronic disease management.

Health and biomedical informatics company Aridhia today announced a strategic partnership with Pivotal, the company setting the new standard for Enterprise PaaS, to create a new technology platform capable of revolutionising the management of chronic health conditions such as cancer, diabetes and cardiovascular disease.

Developing on the Pivotal One™ platform, the companies will work together to provide the international healthcare, life and biomedical science markets with applications and services that enable the rapid, sophisticated analysis of massive amounts of clinical, patient, imaging and genomic data and provide a comprehensive picture of factors affecting each patient’s treatment and healthcare outcomes.

The collaboration will enable clinicians and researchers to gain fresh insights into correlations between patient, clinical and genomic data and usher in a new age of ‘stratified medicine’, offering improved, personalised treatments tailored to the genetics of individual patients.

As chronic diseases such as cancer, diabetes, respiratory and cardiovascular disease become increasingly prevalent worldwide, Aridhia’s CEO and Chairman, Dr David Sibbald, believes healthcare organisations will rely more on real-time data analysis and disease management services to enhance service delivery, stratify patient risk and improve clinical outcomes.

“Chronic diseases are the leading cause of morbidity and mortality in the world.  There is an urgent clinical and economic need to manage those conditions more effectively, which is why we are excited to have the opportunity to join forces with Pivotal.  Medicine and biology are rapidly becoming information sciences and this collaboration will not only allow us to enhance our existing biomedical informatics solutions, but will also deliver the advanced informatics services required for the development of stratified medicine.

“An individual’s genetic profile can have a significant impact on the choice and effectiveness of their treatment plan. Our approach will enable healthcare professionals to treat patients with all the necessary information available at the point of care, presenting data in a way that supports safe, effective and patient-centred health care.

“By combining our health and biomedical informatics expertise with Pivotal’s outstanding capability in real-time, high-capacity analytics and scalability, we are a step closer to our goal of becoming a world leader in the detailed analysis of clinical and scientific information required for the personalised treatment pathways of the future,” says Dr Sibbald.

Chris Roche, Chief Technology Officer in Europe, Middle East and Africa at Pivotal, agrees that the new collaboration has the potential to produce improvements in the treatment and outcomes of tens of millions of people living with chronic disease worldwide. Roche says: “Health and biomedical solutions utilising the latest analytical techniques can enable easier identification of the risks of chronic disease and ensure patient management is as effective as possible. With healthcare budgets being squeezed, and chronic disease a growing problem in an ageing population across the world, the application of advanced analytics aligned to clinical practice will become increasingly important. Applied in this way, the right technology has the potential to assist with the proper targeting of resources, and the effective mitigation of the effects of diabetes, cancer, respiratory and cardiovascular disease worldwide.”

Roche continued “Aridhia has successfully built a team of clinicians, life scientists, data scientists and software developers to tackle simultaneously the complexities of disease management within ever-changing healthcare systems. This multidisciplinary combination of clinical and informatics domain expertise is very rare and we’re extremely pleased to be partnering and collaborating within this field.

With the prohibitive cost of sequencing an individual’s genome continuing to fall rapidly, stratified medicine is widely predicted to be a huge growth area for healthcare providers over the next decade.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Friday, November 20, 2015
Aridhia's Data Platform Chosen for Alzheimer's Research Project
Company announces Northern Ireland based Alzheimer's research collaboration to benefit from AnalytiXagility workspace.
Friday, November 06, 2015
Aridhia, Vancis Collaborate
The companies are joining forces to bring combined cloud collaboration services to Netherlands medical research sector.
Thursday, August 06, 2015
Revolutionary Mini-App Technology to Accelerate Clinical Application Development
Aridhia enhances AnalytiXagility data innovation platform with rapid prototyping technology from leading “R” language tools provider RStudio to accelerate translation of precision medicine and biomedical research into clinical practice.
Thursday, July 09, 2015
Aridhia’s Data Science Platform used in €6M EU Project
The company’s data science platform AnalytiXagility has been chosen to underpin a €6 million oral healthcare innovation project.
Thursday, June 18, 2015
New CEO for Aridhia
Aridhia’s Board of Directors has announced the appointment of Chris Roche as Chief Executive Officer (CEO), succeeding co-founder David Sibbald, who takes up the role of Executive Chairman.
Monday, April 27, 2015
Aridhia Sets Its Sights On Us Market With Craneware Partnership
Partnership will enable Aridhia to offer its core services to Craneware’s US client base.
Tuesday, March 10, 2015
Aridhia Secures Place On G-Cloud 6 Framework
Aridhia’s analytics platform and services will be widely accessible to healthcare providers and research collaborations.
Monday, February 02, 2015
Anonymised Clinical Data Key to Understanding Traumatic Brain Injuries
By exploiting big data in a real healthcare setting, it is hoped that clinicians will be able to make treatment decisions earlier.
Thursday, December 11, 2014
Aridhia Appointed to UK Government’s G-Cloud Framework
The latest in collaborative analytical capability now available on-demand to Government and Healthcare Organisations enabling data-driven healthcare.
Tuesday, June 03, 2014
Aridhia Appoints Former EMC Director Chris Roche
The Company announced today the appointment to a newly created post on its executive team of Chief Commercial Officer.
Tuesday, May 27, 2014
Aridhia Wins Genomics England Competition
Company wins Genomics England-led SBRI competition to accelerate the adoption of genomics medicine.
Thursday, May 08, 2014
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos